You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
耀才团队: 内地新型肺炎确诊个案增至9,692宗
阿思达克 01-31 11:37

耀才证券研究部团队称,隔晚(30日)美股先跌後回升,道指开市曾挫245点至28,489点,美国3个月与10年期国债债息一度倒挂,面对新型肺炎疫情持续扩张,市场避险情绪增加。另外,Facebook业绩反映开支大增,股价亦跌逾6%。美股尾市倒升,市场继续憧憬美企业绩表现,收市後亚马逊公布上季利润胜预期,股价场外升逾一成重上每股2,000美元水平之上。港股ADR普遍回稳,隔晚2月夜期收报26,400点,升50点,低水49点。恒指过去两个交易日累跌逾1,500点,恒指今早(31日)有望略作反弹,但投资者目前实不宜抱太大期望。内地新型冠状病毒肺炎确诊病例增加至9,692宗,死亡人数增至213名,武汉肺炎扩散迅速,美元兑离岸人民币会否於短期後市再跌穿「七算」将成关键。

从技术上看,恒指昨日再一度跌逾833点低见26,330点,虽然人民币回稳带动尾市跌幅略为收窄,但由於恒指已跌穿一道由去年8月15日低位24,899点伸延上来的中期上升轨,若短线恒指未能尽快重越26,500点水平之上,後市宜维持审慎态度,指数有可能顺势下试26,000点心理关口。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account